Diário Cefaleia
0
Quality Score
Niche
Diário Cefaleia
Low confidence
✍️ bumetric analysis
“
Diário Cefaleia is an Android app from Libbs Farmacêutica in the Medical category, currently rated — across few ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Medical app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$500
per month
→
12-mo forecast
$437 – $1575
per month
→
24-mo forecast
$405 – $3644
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD💰 Estimated build cost
$120K
↳ What it cost to build · not monthly revenue
Likely range $90K – $160K
$25K · MVP floor$100K · indie scale$500K+ · studio build
📈Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱MVP baseline (design + 1-store ship) | +$28K |
| 📱5 unique screens × $4.5K | +$22K |
| ⚙Medical complexity ×1.55 | +$27K |
| 🌐Cross-platform reach (iOS + Android) | +$43K |
Total estimate$120K
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$500/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
6 months
$426 – $993
12 months
$437 – $1.6K
24 months
$405 – $3.6K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Early-stage solo · 41/100INDIE TIERexpected for tierGrowth Velocity
5.0
Founder Strength
4.7
Product Quality
5.7
Revenue Strength
2.7
Monetization Maturity
1.0
Defensibility
3.5
Market Position
0.0
Operational Safety
10.0
- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.1★ across 169 reviews — below category median.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $9K-$16K. Portfolio play ($1K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Diário Cefaleia
- Developer
- Libbs Farmacêutica
- Bundle ID
- br.com.applausemobile.cefaleiaphone
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.applausemobile.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $291/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
The Headache Diary was developed to help the patient to mark when, why and how headaches happen, organizing the information in an easy to understand calendar and generating reports that can be shared with the doctor, helping with the treatment.
With a new completely redesigned look, the app is even more complete, now bringing a set of graphics and visual information that will help you understand events in a simple way.
If you have any questions about the app, please contact us:
SAC: 0800 013 5044
E-mail: libbs@libbs.com.br
With a new completely redesigned look, the app is even more complete, now bringing a set of graphics and visual information that will help you understand events in a simple way.
If you have any questions about the app, please contact us:
SAC: 0800 013 5044
E-mail: libbs@libbs.com.br
App Specs
🔐 Own this app? Claim & verify MRR →🔖 vVaries with device📂 Medical💰 Free
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by Libbs Farmacêutica
View all →📦 Portfolio summaryINDIE studio
4apps·$1K/mocombined
✓ Diversified — top app contributes 42%; risk spread across portfolio
About this analysis
Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
Diário Cefaleia is a very early-stage Android app in the medical space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
3 answers · auto-generated from this app's public dataHow much does Diário Cefaleia make per month?▴
Low-confidence model estimate. Diário Cefaleia has only 0 App Store ratings, so our revenue model has very little signal to work with — treat the ~$290/mo figure as directional only, not a verified MRR. No founder-verified revenue data is available for this app. See methodology for the formula and confidence bands.
What apps are like Diário Cefaleia?▴
Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Diário Cefaleia?▴
Diário Cefaleia is published by Libbs Farmacêutica on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.